INS and Hypoglycemia: This nationwide cohort study demonstrated that patients with coexisting T2D and COPD requiring insulin therapy might increase the risk of hospitalization for COPD, bacterial pneumonia, ventilation use, and severe hypoglycemia; however, it did not increase the risk of death.